These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30045399)

  • 21. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional multiphase time-resolved low-dose contrast-enhanced magnetic resonance angiography using TWIST on a 32-channel coil at 3 T: a quantitative and qualitative comparison of a conventional gadolinium chelate with a high-relaxivity agent.
    Giesel FL; Runge V; Kirchin M; Mehndiratta A; Gerigk L; Corell B; von Gall C; Kauczor HU; Essig M
    J Comput Assist Tomogr; 2010; 34(5):678-83. PubMed ID: 20861769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
    Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
    Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appropriate Minimal Dose of Gadobutrol for 3D Time-Resolved MRA of the Supra-Aortic Arteries: Comparison with Conventional Single-Phase High-Resolution 3D Contrast-Enhanced MRA.
    Bak SH; Roh HG; Moon WJ; Choi JW; An HS
    AJNR Am J Neuroradiol; 2017 Jul; 38(7):1383-1390. PubMed ID: 28473338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of blood pool and extracellular gadolinium chelate for functional MR evaluation of vascular thoracic outlet syndrome.
    Lim RP; Bruno M; Rosenkrantz AB; Kim DC; Mulholland T; Kwon J; Palfrey AP; Ogedegbe O
    Eur J Radiol; 2014 Jul; 83(7):1209-1215. PubMed ID: 24840478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose comparison of single- vs. double-dose in contrast-enhanced magnetic resonance angiography of the carotid arteries: Intraindividual cross-over blinded trial using Gd-DTPA.
    Jourdan C; Heverhagen JT; Knopp MV
    J Magn Reson Imaging; 2007 Mar; 25(3):557-63. PubMed ID: 17326082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved vessel delineation in keyhole time-resolved contrast-enhanced MR angiography using a gadolinium doped flush.
    Beranek-Chiu J; Froehlich JM; Wentz KU; Doert AN; Zollikofer CL; Eckhardt BP
    J Magn Reson Imaging; 2009 May; 29(5):1147-53. PubMed ID: 19388120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
    Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M
    Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Systematic analysis of the geometry of a defined contrast medium bolus--implications for contrast enhanced 3D MR-angiography of thoracic vessels].
    Kreitner KF; Kunz RP; Weschler C; Ley S; Krummenauer F; Schreiber WG; Thelen M
    Rofo; 2005 May; 177(5):646-54. PubMed ID: 15871079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three different contrast agents at two different doses (0.05 and 0.1 mmol/kg) in pigs at 1.5 Tesla.
    Voth M; Michaely HJ; Schwenke C; Vos B; Pietsch H
    Eur Radiol; 2011 Feb; 21(2):337-44. PubMed ID: 20809127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-of-Arrival Parametric Maps and Virtual Bolus Images Derived From Contrast-Enhanced Time-Resolved Radial Magnetic Resonance Angiography Improve the Display of Brain Arteriovenous Malformation Vascular Anatomy.
    Schubert T; Wu Y; Johnson KM; Wieben O; Maksimovic J; Mistretta C; Turski P
    Invest Radiol; 2016 Nov; 51(11):706-713. PubMed ID: 27760058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose Reduction in Contrast-Enhanced Cervical MR Angiography: Field Strength Dependency of Vascular Signal Intensity, Contrast Administration, and Arteriographic Quality.
    Dehkharghani S; Qiu D; Albin LS; Saindane AM
    AJR Am J Roentgenol; 2015 Jun; 204(6):W701-6. PubMed ID: 26001259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine.
    Woodard PK; Chenevert TL; Sostman HD; Jablonski KA; Stein PD; Goodman LR; Londy FJ; Narra V; Hales CA; Hull RD; Tapson VF; Weg JG
    Int J Cardiovasc Imaging; 2012 Feb; 28(2):295-301. PubMed ID: 21337023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Congenital heart disease in adults: Quantitative and qualitative evaluation of IR FLASH and IR SSFP MRA techniques using a blood pool contrast agent in the steady state and comparison to first pass MRA.
    Febbo JA; Galizia MS; Murphy IG; Popescu A; Bi X; Turin A; Collins J; Markl M; Edelman RR; Carr JC
    Eur J Radiol; 2015 Oct; 84(10):1921-9. PubMed ID: 26253499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time-resolved MR angiography of renal artery stenosis in a swine model at 3 Tesla using gadobutrol with digital subtraction angiography correlation.
    Morelli JN; Ai F; Runge VM; Zhang W; Li X; Schmitt P; McNeal G; Michaely HJ; Schoenberg SO; Miller M; Gerdes CM; Sincleair ST; Spratt H; Attenberger UI
    J Magn Reson Imaging; 2012 Sep; 36(3):704-13. PubMed ID: 22645046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of four injection profiles for uniform contrast-enhanced signal intensity profiles in MR angiography.
    Maki JH; Wilson GJ; Clark TJ
    J Magn Reson Imaging; 2019 Dec; 50(6):1808-1816. PubMed ID: 31095810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Part 2 - Coronary angiography with gadofosveset trisodium: a prospective intra-subject comparison for dose optimization for 100 % efficiency imaging.
    Ahlman MA; Raman FS; Pang J; Zemrak F; Sandfort V; Penzak SR; Fan Z; Liu S; Li D; Bluemke DA
    BMC Cardiovasc Disord; 2016 Mar; 16():58. PubMed ID: 27004532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model.
    Merkle EM; Dale BM; Barboriak DP
    Acad Radiol; 2007 Jul; 14(7):795-803. PubMed ID: 17574130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of models and contrast agents for improved signal and signal linearity in dynamic contrast-enhanced pulmonary magnetic resonance imaging.
    Bell LC; Wang K; Munoz Del Rio A; Grist TM; Fain SB; Nagle SK
    Invest Radiol; 2015 Mar; 50(3):174-8. PubMed ID: 25501016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gadofosveset trisodium-enhanced abdominal perforator MRA.
    Zou Z; Kate Lee H; Levine JL; Greenspun DT; Allen RJ; Vasile J; Rohde C; Prince MR
    J Magn Reson Imaging; 2012 Mar; 35(3):711-6. PubMed ID: 22031489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.